Simpler Grants.gov #HT942526OCRPOCCTAECI

Army and DHA Seek Early-Career Investigators for Ovarian Cancer Clinical Trial Research Grants

The Department of the Army, through the U.S. Army Medical Research Acquisition Activity (USAMRAA) and the Defense Health Agency's Congressionally Directed Medical Research Programs (CDMRP), is seeking proposals for the Ovarian Cancer Clinical Trial Academy – Early-Career Investigator Award. - Opportunity is part of the FY26 Ovarian Cancer Research Program (OCRP) under the Congressionally Directed Medical Research Programs (CDMRP) - Focus is on supporting early-career investigators (ECIs) to conduct translational research and small-scale, early-phase clinical trials in ovarian cancer - Applicants must: - Be within 12 years of their last postdoctoral research position or clinical fellowship - Commit at least 25% effort to the award and OCCTA activities for the first two years - Have a designated mentor with clinical trial experience - Provide preliminary data and a letter attesting to eligibility - Up to three awards are anticipated, each with a maximum of $1.4 million in funding, totaling approximately $4.2 million - Maximum period of performance is four years per award - Additional award mechanisms in the program include Clinical Trial Award, Investigator-Initiated Research Award, Ovarian Cancer Academy Early-Career Investigator Award, and Pilot Award, with funding ranging from $350,000 to $2.8 million and periods of performance from 2 to 4 years - No specific OEMs or commercial vendors are involved, as this is a research grant opportunity - Notable requirements include strong emphasis on mentoring, professional development, and national networking within the academy structure

Description

The Ovarian Cancer Clinical Trial Academy (OCCTA) supports Early-Career Investigators (ECIs) in clinical trial research to develop effective treatments and cures for ovarian cancer. The program provides professional and leadership development, mentoring, national networking, collaborations, and a peer group for junior clinical trialists. Research funded will support translational research and small-scale, early-phase clinical trials in ovarian cancer, requiring preliminary data. The ECI must be within 12 years of their last postdoctoral research or clinical fellowship and commit at least 25% effort to the award and OCCTA activities for the first two years. A designated mentor with clinical trial experience is required.

View original listing